MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$3,066K
Free Cash flow
-$6,899K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Sales and maturities of availabl...
Share-based compensation expense
Accrued liabilities
Others
Negative Cash Flow Breakdown
Net loss
Inventory
Purchases of available-for-sale ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-15,873
-17,961
-9,394
-16,288
Depreciation and amortization expense
1,888
899
2,808
2,778
Provision for allowance for credit losses
131
112
322
512
Share-based compensation expense
6,463
8,034
7,555
7,998
Non-cash lease expense
532
571
533
556
Amortization of debt issuance costs
243
262
69
75
Debt extinguishment loss
-
-
2,737
-
Amortization (accretion) of premium (discount) on marketable securities, net
-6
-5
4
5
Other Noncash Income Expense
-796
-587
-458
-531
Accounts receivable
-1,495
-11,685
9,518
2,557
Inventory
3,176
335
-5,393
-973
Prepaid expenses and other assets
1,668
-608
-697
615
Other non-current assets
27
293
200
-62
Operating lease liabilities
-829
-854
-825
-829
Accounts payable
2,524
6,811
-9,377
-3,856
Accrued liabilities
2,754
-3,126
778
2,118
Increase Decrease In Other Operating Capital Net
-43
-235
58
-36
Net cash provided by (used in) operating activities
-4,698
7,240
-8,026
-9,092
Purchases of available-for-sale marketable securities
2,598
16,071
5,682
4,640
Sales and maturities of available-for-sale marketable securities
11,867
11,317
17,746
16,185
Purchases of property and equipment
2,201
3,062
2,398
2,809
Acquisition, net of cash acquired
-
-
0
-
Net cash provided by (used in) investing activities
7,068
-7,816
9,666
8,736
Proceeds from interest bearing term debt
-
-
59,310
-
Proceeds from insurance premium financing
983
-
0
570
Debt issuance costs
0
6
1,199
-
Payments on interest bearing term and revolving debt
-
-
56,315
-
Payments on insurance premium financing
269
466
409
409
Proceeds from issuance of common stock from public offering, net of issuance costs and underwriting discount of 7.5 million
-
-
0
-
Proceeds from exercise of employee stock options
8
91
70
241
Taxes from withheld shares
26
207
75
412
Net cash provided by (used in) financing activities
696
-588
1,382
-10
Net increase (decrease) in cash and cash equivalents
3,066
-1,164
3,022
-366
Cash and cash equivalents at beginning of period
9,544
10,708
7,686
11,350
Cash and cash equivalents at end of period
12,610
9,544
10,708
7,686
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Sales and maturities
of...
$11,867K
(-64.48%↓ Y/Y)
Proceeds from insurance
premium financing
$983K
(0.00%↑ Y/Y)
Proceeds from exercise of
employee stock options
$8K
(-96.60%↓ Y/Y)
Net cash provided by
(used in) investing...
$7,068K
(237.22%↑ Y/Y)
Net cash provided by
(used in) financing...
$696K
(-1.28%↓ Y/Y)
Canceled cashflow
$4,799K
Canceled cashflow
$295K
Net increase
(decrease) in cash and cash...
$3,066K
(192.97%↑ Y/Y)
Canceled cashflow
$4,698K
Purchases of
available-for-sale marketable...
$2,598K
(-91.41%↓ Y/Y)
Purchases of property and
equipment
$2,201K
(-73.51%↓ Y/Y)
Share-based compensation
expense
$6,463K
(-64.63%↓ Y/Y)
Accrued liabilities
$2,754K
(151.87%↑ Y/Y)
Accounts payable
$2,524K
(-73.25%↓ Y/Y)
Depreciation and
amortization expense
$1,888K
(-62.52%↓ Y/Y)
Accounts receivable
-$1,495K
(85.03%↑ Y/Y)
Other Noncash Income
Expense
-$796K
(-263.47%↓ Y/Y)
Non-cash lease expense
$532K
(-53.05%↓ Y/Y)
Amortization of debt issuance
costs
$243K
(64.19%↑ Y/Y)
Provision for allowance
for credit losses
$131K
(-77.45%↓ Y/Y)
Increase Decrease In
Other Operating...
-$43K
(24.56%↑ Y/Y)
Amortization (accretion) of
premium (discount) on...
-$6K
(-105.26%↓ Y/Y)
Payments on insurance
premium financing
$269K
(174.49%↑ Y/Y)
Taxes from withheld
shares
$26K
(-93.73%↓ Y/Y)
Net cash provided by
(used in) operating...
-$4,698K
(-509.23%↓ Y/Y)
Canceled cashflow
$16,875K
Net loss
-$15,873K
(52.36%↑ Y/Y)
Inventory
$3,176K
(1.08%↑ Y/Y)
Prepaid expenses and
other assets
$1,668K
(2085.71%↑ Y/Y)
Operating lease
liabilities
-$829K
(46.62%↑ Y/Y)
Other non-current
assets
$27K
(-92.60%↓ Y/Y)
Buy us a coffee
TREACE MEDICAL CONCEPTS, INC. (TMCI)
TREACE MEDICAL CONCEPTS, INC. (TMCI)